Stay updated with breaking news from Meeting Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On December 18, 2023, the Office of Administrative Law ("OAL") approved the California Office of Healthcare Affordability's ("OHCA's") Cost and Market Impact Review regulations...
Data demonstrate a significant 71% reduction in risk of disease progression or death in selinexor + bortezomib + dexamethasone (SVd) arm versus bortezomib + dexamethasone (Vd) arm in PI-naïve
ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer
ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative...
Item 5.07 Submission of Matters to a Vote of Security Holders On May 9, 2023, ENB Financial Corp held its 2023 Annual Meeting of Shareholders . A total of 5,626,631 shares of the Company's common... | May 10, 2023